Faeth Therapeutics CFO Brian Stephenson Acquires $1.1M in Company Stock

Brian Stephenson, Chief Financial Officer of Faeth Therapeutics, Inc., acquired 15,463 shares of common stock through multiple transactions on June 24-26, 2026, with total purchases valued at approximately $1.1 million. The acquisitions occurred at weighted average prices ranging from $23.61 to $27.77 per share. The shares are held indirectly through the Brian Stephenson Revocable Trust, where Stephenson serves as sole trustee with voting and investment power. Following these purchases, Stephenson's total holdings increased to 33,054 shares. The transactions were executed in multiple lots at various price points within specified ranges, as detailed in the footnotes. This Form 4 filing represents significant insider buying activity by the company's CFO, potentially signaling confidence in Faeth Therapeutics' future prospects.